Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study

Neal et al conducted a study to assess whether gastric antisecretory drugs, antibiotics or abdominal surgery are associated with campylobacter infection. The use of omeprazole predisposes to clinical campylobacter infection.

Saved in:
Bibliographic Details
Published in:BMJ 1996-02, Vol.312 (7028), p.414-415
Main Authors: Neal, Keith R, Scott, Helen M, Slack, Richard C B, Logan, Richard F A
Format: Article
Language:English
Subjects:
Aged
Anti-Bacterial Agents - adverse effects
Anti-Ulcer Agents - adverse effects
Antibiotics
Bacteria
Biological and medical sciences
Campylobacter
Campylobacter infections
Campylobacter Infections - chemically induced
Case control studies
Digestive system
Drug therapy
Drug toxicity and drugs side effects treatment
Gastroenteritis
Gastroenteritis - chemically induced
Gastrointestinal agents
Histamine H2 Antagonists - adverse effects
Humans
Infections
Medical sciences
Middle Aged
Odds Ratio
Omeprazole - adverse effects
Pharmacology. Drug treatments
Predisposing factors
Proton pump inhibitors
Risk Factors
Salmonella infections
Surgery
Toxicity: digestive system
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Neal et al conducted a study to assess whether gastric antisecretory drugs, antibiotics or abdominal surgery are associated with campylobacter infection. The use of omeprazole predisposes to clinical campylobacter infection.
ISSN:0959-8138
0959-8146
1468-5833
1756-1833
DOI:10.1136/bmj.312.7028.414